Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Use consistently (morning and night) for visible results
Once-weekly subcutaneous semaglutide is a GLP-1 RA for the treatment of T2DM with proven superior and sustained glycaemic control and weight loss versus all comparators evaluated in the SUSTAIN phase 3 clinical trial programme [15, 16]
It is released in the gut in response to food intake and has several important functions: Insulin Secretion GLP-1 (glucagon-like peptide-1) plays a crucial role in the regulation of blood sugar levels by stimulating the pancreas to produce insulin
Keep reading to discover more
US$ 23.30
US$ 21.14
US$ 21.02
US$ 27.01
US$ 28.35
US$ 28.68
